Tetrahydrocannabinol; products containing, permits to process and dispense cannabidiol oil.

Clarifies that products containing a concentration of tetrahydrocannabinol that is no greater than that allowed by federal law does not constitute marijuana, as defined in the Code. The bill also increases from one to two the number of pharmaceutical processor permits the Board of Pharmacy may issue or renew for each health service area in any year and allows each pharmaceutical processor to whom a permit has been issued by the Board of Pharmacy to operate up to two off-site dispensing locations for the dispensing of cannabidiol oil and THC-A oil. The bill directs the Board of Pharmacy to issue additional permits to operate a pharmaceutical processor by September 1, 2019.